Brief: Kintara Therapeutics Announces Fiscal 2022 Financial Results And Provides Corporate Update
27/09/2022 13:59
Sept 27 (Reuters) - Kintara Therapeutics Inc KTRA.O :
* KINTARA THERAPEUTICS ANNOUNCES FISCAL 2022 FINANCIAL
RESULTS AND
PROVIDES CORPORATE UPDATE
* KINTARA THERAPEUTICS INC FY LOSS PER SHARE $0.52
* KINTARA THERAPEUTICS INC - AT JUNE 30, 2022, KINTARA HAD
CASH
AND CASH EQUIVALENTS OF APPROXIMATELY $11.8 MILLION
* KINTARA THERAPEUTICS INC - REMAIN ON TRACK TO START
ENROLLING
PATIENTS IN CMBC STUDY AROUND END OF SEPTEMBER 2022
Source text for Eikon: ID:nPn8dRjRta
Further company coverage: KTRA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on TuHURA Biosciences
See all newsBrief: Tuhura Biosciences Receives Key U.S. Patent For Its Groundbreaking Delta Opioid Receptor Antibody Drug Conjugate Technology
TuHURA Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Tuhura Biosciences Reports Second Quarter 2026 Financial Results And Provides A Corporate Update
TuHURA Biosciences Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Tuhura Biosciences Inc Enters At The Market Offering Agreement With H.C. Wainwright & Co.